Reisch N

ORCID: 0000-0002-7469-6069 · 3 papers in corpus
observational 2026
Once-daily, late-night, modified-release hydrocortisone rapidly normalizes menstrual cyclicity in women with non-classic congenital adrenal hyperplasia
Human reproduction open ·doi:10.1093/hropen/hoag071

STUDY QUESTION: Does late-night, modified-release hydrocortisone (MR-HC) improve biochemical control and restore menstrual regularity in women with non-classic congenital adrenal hyperplasia (NCCAH)? SUMMARY ANSWER: Once-daily MR-HC substa…

case-report 2022
11-Oxygenated androgens are not secreted by the human ovary: in-vivo data from four different cases of hyperandrogenism
European journal of endocrinology ·doi:10.1530/eje-22-0518

OBJECTIVE: Differentiation of an adrenal from an ovarian source of hyperandrogenemia can be challenging. Recent studies have highlighted the importance of 11-oxygenated C19 steroids to the androgen pool in humans. The aim of this study was …

observational 2020
MON-177 CAH-X Syndrome in a German Cohort of Patients with Congenital Adrenal Hyperplasia
Journal of the Endocrine Society

Abstract Congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CAH) is encoded by the CYP21A2 gene. The CYP21A2 gene is flanked and partially overlapped by the TNXB gene encoding an extracellular matrix protein called Tenascin-X.…